Abbott Laboratories said it plans to spin off its nutrition unit into a separate publicly traded company after a series of missteps have weighed on the company’s broader performance.

Investing.com -- Abbott (NYSE:ABT) ha publicado unos resultados del tercer trimestre que cumplieron las expectativas de beneficios y superaron ligeramente las estimaciones de ingresos, aunque sus acciones cayeron alrededor de un 1,4% antes de la comercialización el miércoles después de que la compañía también revelara sus planes de separar su negocio de Nutrición.

Abbott Laboratories (ABT) informó el miércoles ganancias ajustadas del tercer trimestre de 1,42 dólares por acción diluida, frente a

(AP) — Abbott Laboratories (ABT) on Wednesday reported third-quarter net income of $920 million.On a per-share basis, the Abbott Park, Illinois-based company said it had profit of 53 cents.

ABBOTT PARK, Ill. (AP) — ABBOTT PARK, Ill. (AP) — Abbott Laboratories (ABT) on Wednesday reported third-quarter net income of $920 million.

Abbott Laboratories announced on Wednesday that its net sales in the third quarter of fiscal 2026 came in at $13.01 billion, growing 14.5% year-over-year, while comparable sales grew 7%.Diluted earnin...

Abbott (NYSE: ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an independent, publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands.

Q2 sales rose 13.00 percent to USD 12.59 billion. Abbott Laboratories stock is EUR 90.67 on October

Abbott is scheduled to release third-quarter results before the U.S. open on October 21. At Lang & S

Abbott Laboratories (NYSE:ABT) benefits each time a patient replaces a glucose sensor. Continuous glucose monitoring, or CGM, sales grew 9.5% excluding currency effects in the second quarter of 2026, versus 7.6% in the first quarter. The investment question is whether repeated purchases can sustain profitable growth as competitors improve their products and insurers influence patient […]

Revenue rose 13.00 percent in the second quarter. Abbott Laboratories stock costs EUR 91.93 on Octob

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.